- Home
- AIRE vs AIMD Comparison
AIRE vs AIMD Comparison
Compare AIRE & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- AIMD
- Stock Information
- Founded
- AIRE 2021
- AIMD 1984
- Country
- AIRE United States
- AIMD United States
- Employees
- AIRE 132
- AIMD N/A
- Industry
- AIRE
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- AIMD Health Care
- Exchange
- AIRE Nasdaq
- AIMD Nasdaq
- Market Cap
- AIRE 13.9M
- AIMD 11.9M
- IPO Year
- AIRE N/A
- AIMD N/A
- Fundamental
- Price
- AIRE $0.26
- AIMD $2.94
- Analyst Decision
- AIRE Strong Buy
- AIMD
- Analyst Count
- AIRE 1
- AIMD 0
- Target Price
- AIRE $1.25
- AIMD N/A
- AVG Volume (30 Days)
- AIRE 3.2M
- AIMD 76.6K
- Earning Date
- AIRE 08-21-2025
- AIMD 08-04-2025
- Dividend Yield
- AIRE N/A
- AIMD N/A
- EPS Growth
- AIRE N/A
- AIMD N/A
- EPS
- AIRE N/A
- AIMD N/A
- Revenue
- AIRE $1,853,629.00
- AIMD $106,207.00
- Revenue This Year
- AIRE $369.52
- AIMD N/A
- Revenue Next Year
- AIRE $68.67
- AIMD N/A
- P/E Ratio
- AIRE N/A
- AIMD N/A
- Revenue Growth
- AIRE 1925.60
- AIMD 13.38
- 52 Week Low
- AIRE $0.24
- AIMD $2.00
- 52 Week High
- AIRE $4.49
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- AIRE 23.85
- AIMD 50.61
- Support Level
- AIRE $0.24
- AIMD $3.07
- Resistance Level
- AIRE $0.34
- AIMD $3.34
- Average True Range (ATR)
- AIRE 0.03
- AIMD 0.24
- MACD
- AIRE 0.00
- AIMD 0.04
- Stochastic Oscillator
- AIRE 15.58
- AIMD 60.37
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.